| 0.8421 0.009 (1.07%) | 08-17 00:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.99 | 1-year : | 1.15 |
| Resists | First : | 0.85 | Second : | 0.99 |
| Pivot price | 0.84 | |||
| Supports | First : | 0.82 | Second : | 0.81 |
| MAs | MA(5) : | 0.84 | MA(20) : | 0.84 |
| MA(100) : | 2.62  |
MA(250) : | 5.86 |
|
| MACD | MACD : | -0.2  |
Signal : | -0.2 |
| %K %D | K(14,3) : | 77.7 | D(3) : | 77.7 |
| RSI | RSI(14): 27.8 | |||
| 52-week | High : | 21.54 | Low : | 0.77 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ FTRP ] has closed above bottom band by 50.0%. Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.85 - 0.86 | 0.86 - 0.86 |
| Low: | 0.8 - 0.81 | 0.81 - 0.81 |
| Close: | 0.83 - 0.84 | 0.84 - 0.85 |
Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.
Mon, 15 Aug 2022
Reunion Neuroscience Inc. (Formerly Field Trip Health Ltd.) Reports Fiscal First Quarter 2023 Financial Results ... - GlobeNewswire
Thu, 11 Aug 2022
An Inside Look into Field Trip's Next-Generation Psychedelic, FT-104 - Psychedelic Spotlight
Wed, 29 Jun 2022
Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2022 Financial Results and Provides Business ... - GlobeNewswire
Fri, 29 Apr 2022
Why Field Trip Health Is Dividing in Two — and What This Means for Investors - Psychedelic Spotlight
Thu, 28 Apr 2022
Field Trip Health Ltd. Announces Intention to Separate the Field Trip Discovery and Field Trip Health Divisions Into Two ... - GlobeNewswire
Thu, 28 Apr 2022
Field Trip Health Ltd. Announces Expansion to The Netherlands and Launch of Proprietary Truffle Program - Psychedelic Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 0 (M) |
| Shares Float | 58 (M) |
| Held by Insiders | 3.486e+007 (%) |
| Held by Institutions | 33 (%) |
| Shares Short | 368 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -5.223e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 91.3 % |
| Return on Equity (ttm) | -29 % |
| Qtrly Rev. Growth | 4.86e+006 % |
| Gross Profit (p.s.) | -0.37 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -0.7 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -44 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 322320 |
| Dividend Yield | 0% |
| Dividend Pay Date | 2017-12-12 |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|